Die Klinik Hietzing im 13. Wiener Gemeindebezirk Hietzing ist eines der größten Spitäler von Wien – geführt wird es vom Wiener Gesundheitsverbund – und wurde in den Jahren 1908 bis 1913 unter ...

During the past decade, Krankenhaus Hietzing conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 22 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 14 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus Hietzing" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Amgen" with 4 trials sponsored, "Bayer" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Hietzing" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Hiscia Society for Cancer Research" with 2 trials as a collaborator and "Novartis Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus Hietzing" are "Leukemia, Myeloid, Acute" (4 trials), "Chronic Kidney Disease" (3 trials), "Diabetes Mellitus, Type 1" (3 trials), "Heart Failure" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Krankenhaus Hietzing" in a lesser frequency.

Most popular intervention types in "Krankenhaus Hietzing" are "Drug" (38 trials), "Device" (11 trials), "Other" (10 trials), "Biological" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Baricitinib" (4 trials), "Tirzepatide" (3 trials), "Azacitidine" (2 trials) and "Erlotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus Hietzing" are 58 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Krankenhaus Hietzing". undefined are not yet recruiting, 5 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Krankenhaus Hietzing, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus Hietzing, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".

Krankenhaus Hietzing has several departments that took part in Clinical trials: "Krankenhaus Nord - Klinik Floridsdorf; Abteilung Pulmologie" - 7 trials, "Klinik Ottakring, 1. Med. Abteilung" - 6 trials, "KH Rudolfstiftung, 1. Med. Abt., Wien" - 2 trials, "Krankenhaus Hietzing, 2. Medizinische Abteilung" - 2 trials, "SMZ-Ost, Psychiatric Dep." - 2 trials